Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Accounts Payables (2020 - 2025)

Sotera Health (SHC) has 6 years of Accounts Payables data on record, last reported at $78.0 million in Q4 2025.

  • For Q4 2025, Accounts Payables rose 41.5% year-over-year to $78.0 million; the TTM value through Dec 2025 reached $78.0 million, up 41.5%, while the annual FY2025 figure was $78.0 million, 41.5% up from the prior year.
  • Accounts Payables reached $78.0 million in Q4 2025 per SHC's latest filing, up from $61.4 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $78.0 million in Q4 2025 and bottomed at $51.8 million in Q3 2021.
  • Average Accounts Payables over 5 years is $63.6 million, with a median of $62.5 million recorded in 2021.
  • Peak YoY movement for Accounts Payables: decreased 22.44% in 2024, then skyrocketed 41.5% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $72.9 million in 2021, then grew by 1.74% to $74.1 million in 2022, then fell by 4.18% to $71.0 million in 2023, then fell by 22.44% to $55.1 million in 2024, then surged by 41.5% to $78.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $78.0 million in Q4 2025, $61.4 million in Q3 2025, and $63.7 million in Q2 2025.